 CAMBRIDGE, Mass.--BUSINESS WIRE--Vedanta Biosciences, a leading clinical-stage microbiome company developing a new category of oral therapies using rationally defined bacterial consortia manufactured from clonal cell banks, today announced that members of its executive team will present and host one-on-one meetings at the following virtual investor conferences: Chardan 3rd Annual Microbiome Medicines Summit Date: Monday, March 8, 2021 Presentation Time: 2:00 PM ET H.C. Wainwright Global Life 